|
1
|
Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome.
|
N Engl J Med
|
2006
|
5.70
|
|
2
|
Phase II trial of erlotinib plus concurrent whole-brain radiation therapy for patients with brain metastases from non-small-cell lung cancer.
|
J Clin Oncol
|
2013
|
4.72
|
|
3
|
Role of detection method in predicting breast cancer survival: analysis of randomized screening trials.
|
J Natl Cancer Inst
|
2005
|
4.01
|
|
4
|
Rapamycin derivatives reduce mTORC2 signaling and inhibit AKT activation in AML.
|
Blood
|
2006
|
3.13
|
|
5
|
An adaptive randomized trial of an intermittent dosing schedule of aerosolized ribavirin in patients with cancer and respiratory syncytial virus infection.
|
J Infect Dis
|
2012
|
3.11
|
|
6
|
Fludarabine-melphalan as a preparative regimen for reduced-intensity conditioning allogeneic stem cell transplantation in relapsed and refractory Hodgkin's lymphoma: the updated M.D. Anderson Cancer Center experience.
|
Haematologica
|
2008
|
2.26
|
|
7
|
P0 stage at radical cystectomy for bladder cancer is associated with improved outcome independent of traditional clinical risk factors.
|
Eur Urol
|
2007
|
2.21
|
|
8
|
Quality of life and sexual functioning in cervical cancer survivors.
|
J Clin Oncol
|
2005
|
2.17
|
|
9
|
Antitumor activity of rapamycin and octreotide as single agents or in combination in neuroendocrine tumors.
|
Endocr Relat Cancer
|
2008
|
1.88
|
|
10
|
Modeling the impact of treatment and screening on U.S. breast cancer mortality: a Bayesian approach.
|
J Natl Cancer Inst Monogr
|
2006
|
1.73
|
|
11
|
Nephroureterectomy for treating upper urinary tract transitional cell carcinoma: Time to change the treatment paradigm?
|
BJU Int
|
2006
|
1.70
|
|
12
|
Plasmacytoid urothelial carcinoma, a chemosensitive cancer with poor prognosis, and peritoneal carcinomatosis.
|
J Urol
|
2012
|
1.65
|
|
13
|
Survival in cancer patients undergoing in-hospital cardiopulmonary resuscitation: a meta-analysis.
|
Resuscitation
|
2006
|
1.59
|
|
14
|
Robot assisted extended pelvic lymphadenectomy at radical cystectomy: lymph node yield compared with second look open dissection.
|
J Urol
|
2010
|
1.48
|
|
15
|
Pathologic features of endometrial carcinoma associated with HNPCC: a comparison with sporadic endometrial carcinoma.
|
Cancer
|
2006
|
1.47
|
|
16
|
Combination of gemcitabine and cisplatin is highly active in women with endometrial carcinoma: results of a prospective phase 2 trial.
|
Cancer
|
2010
|
1.46
|
|
17
|
Outcome and patterns of recurrence of nonbilharzial pure squamous cell carcinoma of the bladder: a contemporary review of The University of Texas M D Anderson Cancer Center experience.
|
Cancer
|
2007
|
1.39
|
|
18
|
The activity of taxanes compared with bleomycin, etoposide, and cisplatin in the treatment of sex cord-stromal ovarian tumors.
|
Gynecol Oncol
|
2005
|
1.35
|
|
19
|
Partial cystectomy for muscle invasive urothelial carcinoma of the bladder: a contemporary review of the M. D. Anderson Cancer Center experience.
|
J Urol
|
2006
|
1.35
|
|
20
|
Sensitivity to epidermal growth factor receptor inhibitor requires E-cadherin expression in urothelial carcinoma cells.
|
Clin Cancer Res
|
2008
|
1.30
|
|
21
|
Her-2/neu overexpression and amplification in uterine papillary serous carcinoma.
|
J Clin Oncol
|
2004
|
1.28
|
|
22
|
Lymph node density is superior to TNM nodal status in predicting disease-specific survival after radical cystectomy for bladder cancer: analysis of pooled data from MDACC and MSKCC.
|
J Clin Oncol
|
2008
|
1.26
|
|
23
|
Interobserver and intraobserver variability of a two-tier system for grading ovarian serous carcinoma.
|
Am J Surg Pathol
|
2007
|
1.23
|
|
24
|
Loss of tuberous sclerosis complex-2 function and activation of mammalian target of rapamycin signaling in endometrial carcinoma.
|
Clin Cancer Res
|
2008
|
1.18
|
|
25
|
PML-RARalpha is associated with leptin-receptor induction: the role of mesenchymal stem cell-derived adipocytes in APL cell survival.
|
Blood
|
2003
|
1.17
|
|
26
|
Evaluation of the relevance of lymph node density in a contemporary series of patients undergoing radical cystectomy.
|
J Urol
|
2006
|
1.14
|
|
27
|
Long-term silicone central venous catheters impregnated with minocycline and rifampin decrease rates of catheter-related bloodstream infection in cancer patients: a prospective randomized clinical trial.
|
J Clin Oncol
|
2004
|
1.13
|
|
28
|
Synthetic triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid induces growth arrest in HER2-overexpressing breast cancer cells.
|
Mol Cancer Ther
|
2006
|
1.10
|
|
29
|
Laparoscopic extraperitoneal para-aortic lymphadenectomy in locally advanced cervical cancer: a prospective correlation of surgical findings with positron emission tomography/computed tomography findings.
|
Cancer
|
2010
|
1.09
|
|
30
|
Fas expression in lung metastasis from osteosarcoma patients.
|
J Pediatr Hematol Oncol
|
2005
|
1.05
|
|
31
|
Analgesic and antiemetic requirements after minimally invasive surgery for early cervical cancer: a comparison between laparoscopy and robotic surgery.
|
Ann Surg Oncol
|
2012
|
1.02
|
|
32
|
Patient preferences regarding side effects of chemotherapy for ovarian cancer: do they change over time?
|
Gynecol Oncol
|
2002
|
1.00
|
|
33
|
Ability of clinical grade to predict final pathologic stage in upper urinary tract transitional cell carcinoma: implications for therapy.
|
Urology
|
2007
|
0.98
|
|
34
|
Predictors of inpatient mortality in an acute palliative care unit at a comprehensive cancer center.
|
Support Care Cancer
|
2009
|
0.97
|
|
35
|
Use of palliative sedation for intractable symptoms in the palliative care unit of a comprehensive cancer center.
|
Support Care Cancer
|
2008
|
0.97
|
|
36
|
COX-2 expression correlates with survival in patients with osteosarcoma lung metastases.
|
J Pediatr Hematol Oncol
|
2008
|
0.97
|
|
37
|
The activity of taxanes in the treatment of sex cord-stromal ovarian tumors.
|
J Clin Oncol
|
2004
|
0.96
|
|
38
|
Delphi survey of nursing research priorities.
|
Oncol Nurs Forum
|
2004
|
0.95
|
|
39
|
The cancer pain experience of Israeli adults 65 years and older: the influence of pain interference, symptom severity, and knowledge and attitudes on pain and pain control.
|
Support Care Cancer
|
2005
|
0.95
|
|
40
|
Management of urethral recurrence after orthotopic urinary diversion.
|
BJU Int
|
2009
|
0.94
|
|
41
|
Topical hyaluronic acid vs. standard of care for the prevention of radiation dermatitis after adjuvant radiotherapy for breast cancer: single-blind randomized phase III clinical trial.
|
Int J Radiat Oncol Biol Phys
|
2011
|
0.94
|
|
42
|
Prospective exploratory analysis of cardiac biomarkers and electrocardiogram abnormalities in patients receiving thoracic radiation therapy with high-dose heart exposure.
|
J Thorac Oncol
|
2014
|
0.93
|
|
43
|
Prophylaxis of graft-versus-host disease in unrelated donor transplantation with pentostatin, tacrolimus, and mini-methotrexate: a phase I/II controlled, adaptively randomized study.
|
J Clin Oncol
|
2010
|
0.93
|
|
44
|
Subcutaneous olanzapine for hyperactive or mixed delirium in patients with advanced cancer: a preliminary study.
|
J Pain Symptom Manage
|
2010
|
0.92
|
|
45
|
Predictors of unilateral renal function after open and laparoscopic partial nephrectomy.
|
Urology
|
2009
|
0.91
|
|
46
|
A comparison of World Health Organization tumor grades at recurrence in patients with non-skull base and skull base meningiomas.
|
J Neurosurg
|
2010
|
0.91
|
|
47
|
Prospective multicenter randomized intermediate biomarker study of oral contraceptive versus depo-provera for prevention of endometrial cancer in women with Lynch syndrome.
|
Cancer Prev Res (Phila)
|
2013
|
0.91
|
|
48
|
Adoptive transfer of PR1 cytotoxic T lymphocytes associated with reduced leukemia burden in a mouse acute myeloid leukemia xenograft model.
|
Cytotherapy
|
2010
|
0.91
|
|
49
|
Predisposing risk factors for palmar-plantar erythrodysesthesia when using liposomal doxorubicin to treat recurrent ovarian cancer.
|
Gynecol Oncol
|
2009
|
0.90
|
|
50
|
PSA response to neoadjuvant androgen deprivation therapy is a strong independent predictor of survival in high-risk prostate cancer in the dose-escalated radiation therapy era.
|
Int J Radiat Oncol Biol Phys
|
2012
|
0.89
|
|
51
|
Management and outcome of 239 adolescent and adult rhabdomyosarcoma patients.
|
Cancer Med
|
2013
|
0.89
|
|
52
|
Retrospective analysis of survival outcomes and the role of cisplatin-based chemotherapy in patients with urethral carcinomas referred to medical oncologists.
|
Urol Oncol
|
2012
|
0.88
|
|
53
|
Role of Minimally Invasive Surgery in Gynecologic Oncology: An Updated Survey of Members of the Society of Gynecologic Oncology.
|
Int J Gynecol Cancer
|
2015
|
0.88
|
|
54
|
Venous thromboembolism (VTE) rates following the implementation of extended duration prophylaxis for patients undergoing surgery for gynecologic malignancies.
|
Gynecol Oncol
|
2012
|
0.88
|
|
55
|
Adenoviral mediated interferon-alpha 2b gene therapy suppresses the pro-angiogenic effect of vascular endothelial growth factor in superficial bladder cancer.
|
J Urol
|
2007
|
0.87
|
|
56
|
Quality of life and toxicity from passively scattered and spot-scanning proton beam therapy for localized prostate cancer.
|
Int J Radiat Oncol Biol Phys
|
2013
|
0.86
|
|
57
|
Receptor heterodimerization: a new mechanism for platelet-derived growth factor induced resistance to anti-epidermal growth factor receptor therapy for bladder cancer.
|
J Urol
|
2010
|
0.85
|
|
58
|
Lymphovascular Space Invasion Portends Poor Prognosis in Low-Risk Endometrial Cancer.
|
Int J Gynecol Cancer
|
2015
|
0.83
|
|
59
|
The cancer pain experience of Israeli and American patients 65 years and older.
|
J Pain Symptom Manage
|
2005
|
0.81
|
|
60
|
The search continues: looking for predictive biomarkers for response to mammalian target of rapamycin inhibition in endometrial cancer.
|
Int J Gynecol Cancer
|
2014
|
0.81
|
|
61
|
Lymph node density for patient counselling about prognosis and for designing clinical trials of adjuvant therapies after radical cystectomy.
|
BJU Int
|
2012
|
0.81
|
|
62
|
A randomized control trial of a supervised versus a self-directed exercise program for allogeneic stem cell transplant patients.
|
Psychooncology
|
2009
|
0.80
|
|
63
|
Risk factors for prolonged hospitalization after gynecologic laparoscopic surgery.
|
Gynecol Oncol
|
2012
|
0.80
|
|
64
|
Successful incorporation of robotic surgery into gynecologic oncology fellowship training.
|
Gynecol Oncol
|
2013
|
0.80
|
|
65
|
The role of radical cystectomy in patients with clinical T4b bladder cancer.
|
Urol Oncol
|
2010
|
0.80
|
|
66
|
Relevance of extracapsular extension of pelvic lymph node metastasis in patients with bladder cancer treated in the contemporary era.
|
Cancer
|
2006
|
0.80
|
|
67
|
Risk of residual disease and invasive carcinoma in women treated for adenocarcinoma in situ of the cervix.
|
Gynecol Oncol
|
2013
|
0.79
|
|
68
|
Knife or needles? A cohort analysis of outcomes after radical prostatectomy or brachytherapy for men with low- or intermediate-risk adenocarcinoma of the prostate.
|
Brachytherapy
|
2012
|
0.79
|
|
69
|
Outcome of patients with bladder cancer with pN+ disease after preoperative chemotherapy and radical cystectomy.
|
Urology
|
2008
|
0.79
|
|
70
|
Incidence of trocar site herniation following robotic gynecologic surgery.
|
Gynecol Oncol
|
2013
|
0.79
|
|
71
|
A randomized study comparing chemotherapy followed by G-CSF alone or in combination with GM-CSF for mobilization of peripheral blood stem cells in patients with non-Hodgkin's lymphomas.
|
J Blood Med
|
2010
|
0.78
|
|
72
|
Comparison of doxorubicin cardiotoxicity in pediatric sarcoma patients when given with dexrazoxane versus as continuous infusion.
|
Pediatr Hematol Oncol
|
2010
|
0.78
|
|
73
|
Expression of a surface antigen (MA6) by peripheral blood CD34+ cells is correlated with improved platelet engraftment and may explain delayed platelet engraftment following cord blood transplantation.
|
Stem Cells Dev
|
2015
|
0.77
|
|
74
|
Randomized phase II trial comparing two dose levels of thymoglobulin in patients undergoing unrelated donor hematopoietic cell transplant.
|
Leuk Lymphoma
|
2011
|
0.77
|
|
75
|
Evaluation of intervention to prevent hypomagnesemia in cervical cancer patients receiving combination cisplatin and radiation treatment.
|
Support Care Cancer
|
2009
|
0.77
|
|
76
|
Carcinoma of the Bartholin Gland: A Review of 33 Cases.
|
Int J Gynecol Cancer
|
2016
|
0.75
|
|
77
|
Impact of surgeon volume on patient safety in laparoscopic gynecologic surgery.
|
Gynecol Oncol
|
2012
|
0.75
|
|
78
|
Improved compliance with venous thromboembolism pharmacologic prophylaxis for patients with gynecologic malignancies hospitalized for nonsurgical indications did not reduce venous thromboembolism incidence.
|
Int J Gynecol Cancer
|
2015
|
0.75
|
|
79
|
Reply to Robinson.
|
J Infect Dis
|
2013
|
0.75
|
|
80
|
Make New Friends But Keep the Old: Minimally Invasive Surgery Training in Gynecologic Oncology Fellowship Programs.
|
Int J Gynecol Cancer
|
2015
|
0.75
|
|
81
|
Reply to Fätkenheuer et al.
|
J Infect Dis
|
2013
|
0.75
|
|
82
|
Abnormal Uterine Bleeding as the Presenting Symptom of Hematologic Cancer.
|
Obstet Gynecol
|
2016
|
0.75
|
|
83
|
Timing of infectious complications following breast-conserving therapy with catheter-based accelerated partial breast irradiation.
|
Ann Surg Oncol
|
2014
|
0.75
|
|
84
|
A Comparison Between Appendiceal and Nonappendiceal Neuroendocrine Tumors in Children and Young Adults: A Single-institution Experience.
|
J Pediatr Hematol Oncol
|
2015
|
0.75
|
|
85
|
Soft tissue sarcomas of the popliteal fossa: a single-institution retrospective review.
|
Cancer
|
2010
|
0.75
|